"With 3 doctors voted Best of Atlanta, we are the number one provider of kidney related services in the State of Georgia."

During the past decade, Georgia Nephrology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Georgia Nephrology" #1 collaborator was "Albert Einstein College of Medicine" with 1 trials as a collaborator, "Baylor Research Institute" with 1 trials as a collaborator, "Biocon Limited" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator and "Georgia Nephrology Research Institute" with 1 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Georgia Nephrology" are "Diabetic Glomerulosclerosis" (1 trials), "Diabetic Nephropathies" (1 trials), "Focal Segmental Glomerulosclerosis (FSGS)" (1 trials), "Lupus Erythematosus" (1 trials) and "Lupus Nephritis" (1 trials). Many other conditions were trialed in "Georgia Nephrology" in a lesser frequency.

Most popular intervention types in "Georgia Nephrology" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Itolizumab [Bmab 600]" (1 trials), "PF-06730512" (1 trials) and "There is no intervention" (1 trials). Other intervention names were less common.

The vast majority of trials in "Georgia Nephrology" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Georgia Nephrology". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Georgia Nephrology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Georgia Nephrology, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".